“The Vitamin B12 Receptor CD320 Is a Key Metabolic Dependency and Prognostic Biomarker in Hepatocellular Carcinoma”. Highlights in Science, Engineering and Technology, vol. 162, Apr. 2026, pp. 227-40, https://doi.org/10.54097/wzcyfb37.